Genovis

Research Genovis (GENO.ST) on Bullrun: market cap SEK 1.33B, P/E 65.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 1.33B; P/E is 65.9.

Peer valuation comparison

Latest P/E is 65.93x versus a Healthcare sector median of 24.64x (167.6% above).

Latest P/E is 65.93x versus a Sweden median of 18.18x (262.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-06SEK 1.33B65.9n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Genovis

Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease. It also offers GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Abera Bioscience AB (ABERA.ST) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU) Active Biotech AB (ACTI) AlzeCure Pharma (ALZCUR) Alzinova (ALZ.ST) Annexin Pharmaceuticals (ANNX.ST) Alligator Bioscience AB (ATORX) BioInvent International (BINV.ST) BioArctic AB (publ) (BIOA-B) Biosergen AS (BIOSGN) Biovica International AB (publ) (BIOVIC-B)

Frequently asked questions

What is Genovis's market cap?

Genovis's market capitalization is SEK 1.33B.

What is Genovis's P/E ratio?

Genovis's price-to-earnings (P/E) ratio is 65.9.

What does Genovis do?

Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease.